Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3261
Abstract: Our aim was to compare the efficacy and safety of two recently developed biosimilars of pegfilgrastim, a pegylated form of the recombinant human granulocyte‐colony stimulating factor (G‐CSF) analog filgrastim with those of the reference pegfilgrastim.… read more here.
Keywords: efficacy safety; safety; reference; pegfilgrastim ... See more keywords
[Effectiveness and safety of two phototherapy devices for the humanised management of neonatal jaundice].
Sign Up to like & getrecommendations! Published in 2019 at "Anales de pediatria"
DOI: 10.1016/j.anpedi.2019.02.008
Abstract: INTRODUCTION Neonatal jaundice is common, especially in premature infants. Compliance with treatment protocols and standard serum bilirubin curves forces the clinician to separate the child from the mother after birth for short phototherapy. The objective… read more here.
Keywords: effectiveness safety; jaundice; bilirubin; neonatal jaundice ... See more keywords
Improving patient safety in two French hospitals: why teamwork training is not enough.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of health organization and management"
DOI: 10.1108/jhom-02-2020-0045
Abstract: PURPOSE The persistent challenges that healthcare organizations face as they strive to keep patients safe attests to a need for continued attention. To contribute to better understanding the issues currently defying patient safety initiatives, this… read more here.
Keywords: two french; improving patient; safety two; patient safety ... See more keywords
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10111865
Abstract: We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and randomized at… read more here.
Keywords: immunogenicity safety; safety; efficacy immunogenicity; two dose ... See more keywords